CALI.CN - FinCanna Capital Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.1500
-0.0100 (-6.25%)
At close: 1:25PM EST
Stock chart is not supported by your current browser
Previous Close0.1600
Open0.1500
Bid0.15 x 0
Ask0.16 x 0
Day's Range0.1500 - 0.1500
52 Week Range0.0800 - 0.8300
Volume17,500
Avg. Volume209,447
Market Cap14.803M
Beta (3Y Monthly)4.22
PE Ratio (TTM)N/A
EPS (TTM)-0.13
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire5 days ago

    FinCanna Closes Convertible Debenture Financing Totaling $4.8 Million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that further to its news release of January 11, 2019 wherein it announced the closing of the first tranche of its oversubscribed Secured Convertible Debentures (“Debentures”) financing of $2.4 million, FinCanna has upsized and closed the second and final tranche of the financing for an additional $2.4 million.  The aggregate proceeds of this financing total $4.8 million. The Debentures will be secured by a general security interest, will mature two years from closing and will bear interest at 12% per annum, payable in cash or, at the option of the Subscriber, in common shares of FinCanna ("Common Shares") subject to certain conditions.

  • GlobeNewswire12 days ago

    FinCanna Announces Final Upsize to Convertible Debenture Financing to total $4.5 Million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that further to its news releases of January 11 and January 30, 2019 wherein it announced the closing of its oversubscribed Secured Convertible Debentures (“Debentures”) financing in the amount of $2.4 million with firm commitments for an additional $1.875 million, today advises that it has increased the size of its second tranche financing to $2.1 million for an aggregate total of $4.5 million. The Debentures will be secured by a general security interest, will mature two years from closing and will bear interest at 12% per annum, payable in cash or, at the option of the Subscriber, in common shares of FinCanna ("Common Shares") subject to certain conditions.

  • GlobeNewswire16 days ago

    FinCanna Signs Royalty Agreement with Multi Brand Manufacturer, QVI, of Sonoma County, California

    QVI is strategically located in Sonoma, California, between the famed Emerald Triangle and the greater San Francisco Bay Area.  QVI is currently refitting its 8,300 square foot facility in Santa Rosa, CA with dedicated spaces for a large-scale commercial kitchen for baked goods, chocolate products and a hard candy and gummy line. The facility will also have a designated area for contract manufacturing for additional products including topicals and tinctures, vapes, pre-rolls, flower assembly and packaging services.

  • GlobeNewswire17 days ago

    FinCanna Upsizes Convertible Debenture Financing to total $4.275 Million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that further to its news release of January 11, 2019 wherein it announced the closing of its oversubscribed Secured Convertible Debentures (“Debentures”) financing in the amount of $2.4 million with firm commitments for an additional $1.25 million to close in a second tranche, today advises that it has increased the size of its second tranche financing to $1.875 million, scheduled to close on or before February 8, 2019, as previously announced. The Debentures will be secured by a general security interest, will mature two years from closing and will bear interest at 12% per annum, payable in cash or, at the option of the Subscriber, in common shares of FinCanna ("Common Shares") subject to certain conditions.

  • GlobeNewswirelast month

    FinCanna Increases and Closes Convertible Debenture Financing of $2.4 Million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce that further to its news releases dated January 4 and 7, 2019, it is upsizing and closing its oversubscribed Secured Convertible Debentures (“Debentures”) financing in the amount of $2.4 million. Furthermore, the company has received firm commitments for an additional $1.25 million to close in a second tranche on or before February 8, 2019. The Debentures will be secured by a general security interest, will mature two years from closing and will bear interest at 12% per annum, payable in cash or, at the option of the Subscriber, in common shares of FinCanna ("Common Shares") subject to certain conditions.

  • GlobeNewswirelast month

    FinCanna Increases Convertible Debenture Financing to $2.0 Million

    The Debentures will be secured by a general security interest, will mature two years from closing and will bear interest at 12% per annum, payable in cash or, at the option of the Subscriber, in common shares of FinCanna ("Common Shares") subject to certain conditions. The Debenture is convertible into Common Shares at $0.20 per share.

  • GlobeNewswirelast month

    FinCanna Announces Convertible Debenture Financing to Raise CAD $1.5 million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry announces its intention to raise CAD$1.5 million by way of Secured Convertible Debentures (“Debentures”). The Debentures will be secured by a general security interest, will mature two years from closing and will bear interest at 12% per annum, payable in cash or, at the option of the Subscriber, in common shares of FinCanna ("Common Shares") subject to certain conditions.

  • GlobeNewswirelast month

    FinCanna Portfolio Company, Refined Resin Technologies Acquires Key Distribution License

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF), a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce that its investee company Refined Resin Technologies Inc. (“Refined Resin”) of Oakland, California, has been issued its California state, “Adult-Use and Medicinal – Temporary Distributor License” (“Temporary Distributor License”). Refined Resin is a cannabinoid research and extraction company that provides B2B products and services to licensed dispensaries, licensed infused product manufacturers and licensed distributors in the medical cannabis supply chain.

  • GlobeNewswire2 months ago

    FinCanna Portfolio Company, Refined Resin Technologies Acquires Key Manufacturing License

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that its investee company Refined Resin Technologies Inc. (“Refined Resin”) of Oakland, California, has achieved its California state, Temporary Manufacturing License for Adult and Medicinal Cannabis Products (“Temporary Manufacturing License”). Refined Resin is a cannabinoid research and extraction company that provides B2B products and services to licensed brands, licensed dispensaries and licensed distributors in the medical cannabis supply chain.

  • GlobeNewswire2 months ago

    FinCanna Advances Final Tranche of Capital to Refined Resin Technologies Inc.

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF), a royalty company for the U.S. licensed medical cannabis industry, has advanced US $750,000, the third and final tranche of its US $3 million capital commitment, to its investee company Refined Resin Technologies Inc. (“Refined Resin”) of Oakland, California. Refined Resin is a cannabinoid research and extraction company that provides B2B and B2C products and services to licensed dispensaries and distributors in the medical cannabis supply chain. This capital is the third and final tranche to be advanced as Refined Resin implements its three-phase development strategy to operationalize its legally zoned, 6,000 square foot, state-of-the-art medical cannabis extraction laboratory.

  • GlobeNewswire3 months ago

    FinCanna Capital to Attend The Private Capital Markets Association of Canada Inaugural Western National Industry Conference

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that it will be a panel presenter at The Private Capital Markets Association of Canada (“PCMA”) to be held at The Glencoe Club, Calgary AB, Thursday November 22. The PCMA is the national voice for private capital market participants and represents the interests of exempt market dealers, issuers and industry professionals to securities regulators, government, industry associations and the public.  The Conference will feature panel presentations and discussions with a variety of engaging speakers and experts allowing attendees to expand their industry network while obtaining valuable insights into an ever-changing global capital market investment industry.